ALT — Altimmune Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Altimmune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	216	190	185	198	132
Net Total Accounts Receivable
Net Total Receivables	12.4	5.84	2.54	4.85	3.12
Prepaid Expenses
Total Other Current Assets
Total Current Assets	230	204	193	210	137
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.96	2.25	1.68	1.01	2.05
Net Intangible Assets
Other Long Term Assets
Total Assets	245	219	207	211	139
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	12	18.3	17.1	12.1	10.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	19.2	19.7	21.6	16.5	15.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	226	199	185	194	124
Total Liabilities & Shareholders' Equity	245	219	207	211	139
Total Common Shares Outstanding